Ioachim E E, Goussia A C, Machera M, Tsianos E V, Kappas A M, Agnantis N J
Department of Pathology, University of Ioannina, Medical School, Ioannina, Greece.
Anticancer Res. 1999 May-Jun;19(3A):2147-55.
The immunohistochemical Cathepsin D (CD) expression of tumour and stromal cells was investigated in a series of 93 human colorectal adenocarcinomas and 22 adenomas with the intention to evaluate its prognostic significance and its contribution in the metastatic potential of colorectal cancer. CD expression was correlated with the expression of extracellular matrix components (collagen type IV, laminin and fibronectin), p53 protein, pRb, bcl-2, c-erbB-2, EGFR, proliferation indices (Ki-67, PCNA) as well as with other conventional clinicopathological features. CD expression (> 10% of positive tumour cells) was observed in 60.2% of carcinomas and in 72.7% of adenomas. Stromal CD expression was detected in all cases. A statistically significant positive correlation between neoplastic cells CD and stromal cells CD (SCCD) was observed in both carcinomas and adenomas. Cancer cells CD (CCCD) was positively correlated with collagen type IV and pRb expression as well as with PCNA score. In carcinomas, SCCD expression was statistically correlated with p53 protein and pRb expression and a trend for correlation with PCNA score was found. These data suggest that Cathepsin D of cancer and stromal cells, especially in combination with other markers, may provide more information about the biological behaviour of colorectal cancer.
在93例人类结肠腺癌和22例腺瘤中,研究了肿瘤细胞和基质细胞组织蛋白酶D(CD)的免疫组化表达,旨在评估其预后意义及其在结直肠癌转移潜能中的作用。CD表达与细胞外基质成分(IV型胶原、层粘连蛋白和纤连蛋白)、p53蛋白、pRb、bcl-2、c-erbB-2、表皮生长因子受体(EGFR)、增殖指数(Ki-67、增殖细胞核抗原)以及其他传统临床病理特征的表达相关。在60.2%的癌组织和72.7%的腺瘤组织中观察到CD表达(阳性肿瘤细胞>10%)。所有病例均检测到基质CD表达。在癌组织和腺瘤组织中,肿瘤细胞CD与基质细胞CD(SCCD)之间均观察到具有统计学意义的正相关。癌细胞CD(CCCD)与IV型胶原、pRb表达以及增殖细胞核抗原评分呈正相关。在癌组织中,SCCD表达与p53蛋白和pRb表达具有统计学相关性,并且发现与增殖细胞核抗原评分有相关趋势。这些数据表明,癌细胞和基质细胞的组织蛋白酶D,尤其是与其他标志物联合时,可能为结直肠癌的生物学行为提供更多信息。